Olanzapine Tablet, Orally Disintegrating
Product Images NDC 51407-261

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 51407-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-261-30lb Olanzapine 5 mg Odt.jpg (51407 261 30lb Olanzapine 5 mg Odt)

51407-261-30lb Olanzapine 5 mg Odt.jpg (51407 261 30lb Olanzapine 5 mg Odt)
This is a package of orally disintegrating tablets of Olanzapine. The package contains 30 tablets, each with a strength of 5 mg. Dosage instructions can be found in the package insert. The tablets should be stored at a temperature of 15°C to 30°C (59°F to 88°F) and protected from light and moisture. Dispense the medication in a tight, light-resistant container and keep it out of reach of children. Each tablet contains 5 mg of Olanzapine. The package has been manufactured by Apotex Inc. in Canada and packaged by GSMS, Incorporated in Camarillo, USA.*
FDA Label Image

51407-262-30lb Olanzapine 10 mg Odt.jpg (51407 262 30lb Olanzapine 10 mg Odt)

51407-262-30lb Olanzapine 10 mg Odt.jpg (51407 262 30lb  Olanzapine 10 mg Odt)
GSMS Incorporated is a manufacturer of Olanzapine Orally Disintegrating Tablets of 10mg strength. The tablets come in a package of 30, and their usage information can be found in the package insert. The tablets should be stored at a temperature between 20°C to 25°C, with permissible excursions between 15°C to 30°C. They should be protected from light and moisture and kept in a tight, light- resistant container. The medication guide for the tablet should be given to each patient by their pharmacist. The tablets of Olanzapine are manufactured by Apotex Ing from Toronto, Canada, and the address of GSMS Incorporated is mentioned in Camarillo, California.*
FDA Label Image

51407-263-30lb (OLANZAPINE 15 MG ODT.jpg)

51407-263-30lb (OLANZAPINE 15 MG ODT.jpg)
This is a description of a medication called Olanzapine, which is manufactured by Apotex Inc. and packaged by GSMS Incorporated. The medication comes in the form of tablets that contain 15 mg of Olanzapine. It is recommended to keep the medication in a tight light-resistant container and protect from light and moisture. The medication should be dispensed with the enclosed Medication Guide to each patient. The package insert should be referred for dosage information. The product should be stored at 20° to 25°C (68° to 77°F) with excursions permitted from 15” to 30"C (59° to 86°F).*
FDA Label Image

51407-264-30lb (OLANZAPINE 20 MG ODT.jpg)

51407-264-30lb (OLANZAPINE 20 MG ODT.jpg)
The text describes a medication called Olanzapine Tablets, USP, containing 20 mg of the active ingredient per tablet. The medication is orally disintegrating and is supplied in a package of 30 tablets. Dosage information can be found in the package insert. The medication should be stored in a tight, light-resistant container, protected from light and moisture and kept away from children. The manufacturer is Apotex Inc. in Toronto, Canada, and it is repackaged by GSMS Incorporated in California, USA.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.